Jacobson Pharma Corporation Limited (2633.HK)

HKD 1.01

(0.0%)

Gross Profit Summary of Jacobson Pharma Corporation Limited

  • Jacobson Pharma Corporation Limited's latest annual gross profit in 2023 was 620.47 Million HKD , down -16.96% from previous year.
  • Jacobson Pharma Corporation Limited's latest quarterly gross profit in 2023 FY was 620.47 Million HKD , down -16.96% from previous quarter.
  • Jacobson Pharma Corporation Limited reported a annual gross profit of 747.17 Million HKD in annual gross profit 2022, up 20.41% from previous year.
  • Jacobson Pharma Corporation Limited reported a annual gross profit of 620.52 Million HKD in annual gross profit 2021, up 16.17% from previous year.
  • Jacobson Pharma Corporation Limited reported a quarterly gross profit of 319.39 Million HKD for 2023 Q4, down 0.0% from previous quarter.
  • Jacobson Pharma Corporation Limited reported a quarterly gross profit of 301.07 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of Jacobson Pharma Corporation Limited (2023 - 2013)

Historical Annual Gross Profit of Jacobson Pharma Corporation Limited (2023 - 2013)

Year Gross Profit Gross Profit Growth
2023 620.47 Million HKD -16.96%
2022 747.17 Million HKD 20.41%
2021 620.52 Million HKD 16.17%
2020 534.14 Million HKD -20.25%
2019 669.75 Million HKD -0.73%
2018 674.65 Million HKD 9.23%
2017 617.66 Million HKD 10.91%
2016 556.88 Million HKD 14.17%
2015 487.75 Million HKD 26.79%
2014 384.7 Million HKD -9.45%
2013 424.84 Million HKD 0.0%

Peer Gross Profit Comparison of Jacobson Pharma Corporation Limited

Name Gross Profit Gross Profit Difference
Pak Fah Yeow International Limited 167.43 Million HKD -270.574%
Grand Pharmaceutical Group Limited 6.52 Billion HKD 90.489%
Extrawell Pharmaceutical Holdings Limited 28.77 Million HKD -2055.999%
Wai Yuen Tong Medicine Holdings Limited 394.81 Million HKD -57.157%
Qianhai Health Holdings Limited -35.6 Million HKD 1842.76%
Lee's Pharmaceutical Holdings Limited 551.31 Million HKD -12.545%
Essex Bio-Technology Limited 1.53 Billion HKD 59.691%
Tongfang Kontafarma Holdings Limited 471.29 Million HKD -31.654%
PuraPharm Corporation Limited 216.62 Million HKD -186.423%
SSY Group Limited 3.48 Billion HKD 82.217%
JBM (Healthcare) Limited 319.41 Million HKD -94.253%
China Resources Pharmaceutical Group Limited 43.36 Billion HKD 98.569%